Aptose Biosciences (NASDAQ:APTO) Receives New Coverage from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Aptose Biosciences (NASDAQ:APTO – Free Report) (TSE:APS) in a research note published on Sunday morning. The firm issued a hold rating on the biotechnology company’s stock. A number of other equities analysts have also issued reports on the company. HC Wainwright restated a buy rating and issued a $7.00 […]

Leave a Reply

Your email address will not be published.

Previous post Texas Capital Bancshares, Inc. (NASDAQ:TCBI) Given Consensus Recommendation of “Reduce” by Brokerages
Next post Color Star Technology (NASDAQ:ADD) and Grand Canyon Education (NASDAQ:LOPE) Head-To-Head Survey